Post-approval studies (Phase 4)Study completedNCT01882322
What this trial is testing
Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Who this might be right for
de Novo Liver Transplant Subjects
Astellas Pharma Korea, Inc. 36